Skip to main content
logo
Kringle Pharma, Inc. (TYO:4884)
Japan flag Japan · Delayed Price · Currency is JPY
445.00
-11.00 (-2.41%)
Aug 27, 2026, 3:30 PM JST

Kringle Pharma Financials Overview

Millions JPY. Fiscal year is Oct - Sep.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Revenue
342.21728069391289
Revenue Growth
372.42%-10.00%15.94%-82.35%35.29%-38.12%
Gross Profit
271.82728069303218
Operating Income
-804.88-909-817-889-426-358
Net Income
-808.44-916-756-854-331-301
Earnings Per Share
-110.24-133.88-118.14-158.44-68.16-72.47
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Cash (Debt)
1,0681,6192,3132,1362,7562,137
Net Cash Growth
-34.57%-30.00%8.29%-22.50%28.97%1.67%
Net Cash Per Share
145.60236.63361.45396.27567.55514.49
Cash & Investments
1,0681,6192,3132,1362,7562,137

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Operating Cash Flow
--755-661-68915-560
Free Cash Flow
--755-661-68915-560
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Gross Margin
79.43%100.00%100.00%100.00%77.49%75.43%
Operating Margin
-235.20%-1262.50%-1021.25%-1288.41%-108.95%-123.88%
Pretax Margin
-235.73%-1270.83%-943.75%-1236.23%-84.40%-103.81%
Profit Margin
-236.24%-1272.22%-945.00%-1237.68%-84.66%-104.15%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
PS Ratio
10.9043.8772.0062.586.1913.56